Feds give researchers ok for safety test of adult stem cells in patients with heart disease
Researchers at Case Western Reserve University School of Medicine and University Hospitals of Cleveland announced that the Food and Drug Administration (FDA) has approved plans to begin a study to evaluate the safety of using adult stem cells from bone marrow to treat chronic ischemia, a serious form of heart disease. . The FDA has approved a Phase I study designed to test the safety of the proce...